CooperVision International Limited
Clinical trials sponsored by CooperVision International Limited, explained in plain language.
Contact lens manufacturer, subsidiary of The Cooper Companies.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New contact lens trial aims to simplify presbyopia prescriptions Results expected Sep 2026 (estimated)
- Can a new lens design improve overnight vision correction? Results expected Dec 2026 (estimated)
-
New contact lenses aim to stop kids from becoming nearsighted
Prevention Recruiting nowThis study tests whether dual focus contact lenses can prevent myopia (nearsightedness) in children aged 8 to 10 who are at risk. Over 2 years, researchers will check if these lenses stop the onset of myopia compared to standard lenses. If it works, it could offer a simple way to…
Sponsor: CooperVision International Limited (CVIL) • Aim: Prevention
Last updated Jul 18, 2026 00:00 UTC
-
Which contact lens is best for aging eyes? new study aims to find out
Symptom relief Recruiting nowThis study compares two daily disposable multifocal contact lenses for people with presbyopia, an age-related condition that makes it hard to see up close. About 35 adults who already wear soft contact lenses will test each lens for one week. The goal is to see which lens provide…
Sponsor: CooperVision International Limited (CVIL) • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC